Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Proffered Paper session - CNS tumours

2644 - radiological phenotyping of idh mutation status in gliomas using dynamic susceptibility contrast perfusion-weighted mri.


19 Oct 2018


Proffered Paper session - CNS tumours


Staging and Imaging

Tumour Site

Central Nervous System Malignancies


Diana Roettger


Annals of Oncology (2018) 29 (suppl_8): viii122-viii132. 10.1093/annonc/mdy273


D. Roettger1, E. Sanverdi2, C. Sudre2, S. Brandner2, V. Katsaros2, S. Bisdas2

Author affiliations

  • 1 R&d, Image Analysis Ltd, SW1V 1BA - London/GB
  • 2 Institute Of Neurology, University College London, NW1 2BU - London/GB


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 2644


Gliomas staging and prognosis has been recently related to the mutation of the gene encoding isocitrate dehydrogenase (IDH). Dynamic Susceptibility Contrast Perfusion-Weighted Imaging (DSC-PWI) is an established MRI technique for glioma staging and prognosis but its value for non-invasive IDH phenotyping has not been thoroughly investigated. Combining DSC-PWI with advanced image analysis methods, such as texture analysis and machine learning, has the potential to increase the diagnostic accuracy of DSC MRI for IDH mutation status detection.


Our retrospective, multi-centre study included 365 patients [184 female; 181 male, median age: 49 (range 21-81 years)], who had been immunohistopathologically diagnosed with gliomas (198 IDH positive; 167 IDH negative). A fully adaptive Bayesian method was applied to calculate leakage-corrected relative cerebral blood volume (rCBV) maps from the DSC raw data. Tumour boundaries were manually defined and co-registered to the rCBV maps. The texture features were calculated based on the rCBV findings within the defined tumour. A 2-fold cross-validation setting of 1000 iterations using support vector machine and multinomial ordinal regression was applied to assess the predictive power of the extracted features in IDH phenotyping.


The proposed rCBV analysis for IDH status stratification showed a sensitivity rate of 75% and specificity rate of 88%. In the non-parametric Wilcoxon test nine out of the ten classical histogram statistics and 12 texture features appeared significantly different across mutation status (p < 0.02). The distance error (difference between the real and predicted grade) was used to show the classification across grading: In 90.2 % of the cases the same features led to inferior or equal to 1 in and in 71.3% of cases to an exact prediction.


These promising preliminary results for DSC-MRI-based glioma stratification with respect to their IDH mutation status suggest further exploration into the potential diagnostic and predictive and predictive value of rCBV analysis as surrogate non-invasive biomarker for IDH classification of gliomas.

Clinical trial identification

Legal entity responsible for the study

University College London.


Has not received any funding.

Editorial Acknowledgement


D. Roettger: Head of Scientific and Medical Affairs: IAG. All other authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.